ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

538 results

Prophylactic Rivaroxaban therapy for left ventricular thrombus after anterior ST segment elevation myocardial infarction

21 Apr 2022

The aim of the current study was to investigate the effects of rivaroxaban on left ventricle thromboprophylaxis in patients with anterior STEMI.

Elad Asher

Reviewer

Elad Asher
Prophylactic Rivaroxaban therapy for left ventricular thrombus after anterior ST segment elevation myocardial infarction

EROSION III: a multicenter RCT of OCT-guided reperfusion in STEMI with early infarct artery patency

19 Apr 2022

This is an interesting study showing that in patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary PCI.

Reviewer

Salvatore Brugaletta
EROSION III: a multicenter RCT of OCT-guided reperfusion in STEMI with early infarct artery patency

GHATI: Improving STEMI management internationally

05 Apr 2022

Mirvat Alasnag interviews Cesar Herrera, Hadley Wilson & Benny Levenson, principal investigators of the GHATI trial: A two-year report of 4,015 patients enrolled in the American College of Cardiology - Global Heart Attack Treatment Initiative.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
GHATI: Improving STEMI management internationally

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

PCRonline @ ACC 2022 Scientific Sessions

29 Mar 2022

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

PCRonline @ ACC.22 Scientific Sessions

COMPLETE: Effects of complete revascularization on angina-related quality of life in patients with ST-segment elevation myocardial infarction

22 Mar 2022

In this interview, Mirvat Alasnag asks Shamir R. Mehta about the results of a prespecified analysis of the COMPLETE study which he presented during the ACC 2022 Scientific sessions. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
COMPLETE: effects of complete revascularization on angina-related quality of life in patients with ST-segment elevation myocardial infarction

Risk of cardiovascular hospital admission after exposure to fine particulate pollution

23 Feb 2022

This current study explored the effect of heavy particle pollution on total cardiovascular admissions, whilst also looking at risk for specific cardiovascular diagnoses, such as angina, myocardial infarction, and ischaemic stroke.

Reviewer

Bawan Abdulaziz
Kalpa De Silva

Reviewer

Kalpa De Silva
Risk of cardiovascular hospital admission after exposure to fine particulate pollution

Unusual case of STEMI - To stent or not to stent or any other alternative?

07 Mar 2022

A 70-year-old gentleman with background of hypertension and smoking presented with STEMI. Coronary angiogram showed ectasia in the mid and distal segment with heavy thrombus burden.

Sandeep Basavarajaiah

Author

Sandeep Basavarajaiah
How should I treat? - Unusual Case of STEMI; To Stent or not to Stent or any other Alternative?

Improved 3-year cardiac survival after IVUS-guided long DES implantation: a patient-level analysis from 2 randomized trials

02 Feb 2022

This study aimed to increase the power to detect differences in patient survival (freedom from cardiac deaths) with IVUS versus angiography guidance by pooling the individual patient data from the IVUS-XPL and ULTIMATE trials.

Nicola Ryan

Reviewer

Nicola Ryan
Improved 3-year cardiac survival after IVUS-guided long DES implantation: a patient-level analysis from 2 randomized trials

Ticagrelor monotherapy after PCI in high-risk patients with prior MI: a prespecified TWILIGHT substudy

31 Jan 2022

In this prespecified subgroup analysis of the TWILIGHT trial, the authors report the impact of prior MI on treatment effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients at least three months post PCI...

Nicola Ryan

Reviewer

Nicola Ryan
Ticagrelor monotherapy after PCI in high-risk patients with prior MI: a prespecified TWILIGHT substudy